TickerFacts.

CervoMed Inc. (CRVO): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$3.48M
Year ended 2022-12-31
2010-12-31: -$7.59M2011-12-31: -$16.36M2012-12-31: -$11.63M2013-12-31: -$12.68M2014-12-31: -$14.05M2015-12-31: -$6.38M2020-12-31: -$15.87M2021-12-31: -$24.58M2022-12-31: -$3.48M-$3.48M
2010-12-31 EBITDA (USD) 2022-12-31
Period endedEBITDAChange YoYSource filing
2022-12-31-$3.48Mn/m2024-03-29, From 2022-01-01
2021-12-31-$24.58Mn/m2023-03-24, From 2021-01-01
2020-12-31-$15.87Mn/a2022-03-18, From 2020-01-01
No annual figure between 2015-12-31 and 2020-12-31.
2015-12-31-$6.38Mn/m2017-03-31, From 2015-01-01
2014-12-31-$14.05Mn/m2016-03-25, From 2014-01-01
2013-12-31-$12.68Mn/m2015-04-03, From 2013-01-01
2012-12-31-$11.63Mn/m2014-04-23, From 2012-01-01
2011-12-31-$16.36Mn/m2013-04-24, From 2011-01-01
2010-12-31-$7.59Mn/a2012-05-21, From 2010-01-01